Rare diseases
Investigational molecules
Locations
Back to Poland1 013 clinical trials in Lodz, Poland across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandStudy on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis
PolandStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
PolandStudy on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome
PolandStudy on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
PolandStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
PolandLong-Term Safety Study of LUM-201 (Ibutamoren Mesilate) in Children with Growth Hormone Deficiency
PolandStudy on the Long-term Safety and Effectiveness of Sibeprenlimab for Patients with Immunoglobulin A Nephropathy (IgAN)
PolandStudy of Anifrolumab for Children and Teens with Moderate to Severe Lupus
PolandStudy on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage
PolandStudy on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation
PolandStudy Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on respiratory viral infections and preventive vaccines, particularly targeting RSV and influenza in older adults. Studies evaluate vaccine efficacy and immune responses to protect against severe respiratory diseases.
Multiple studies assess combination vaccines and co-administration strategies to enhance protection against multiple respiratory pathogens.
Innovative research examining treatments for plaque psoriasis and related conditions. Trials investigate novel therapeutic approaches including oral medications and biological treatments for moderate to severe cases.
Studies focus on measuring improvement in disease severity and quality of life outcomes for patients.
Comprehensive research on meningococcal and pneumococcal vaccines, with special attention to pediatric populations. Studies evaluate safety profiles and immune responses across different age groups.
Trials incorporate multiple age cohorts from infants to adolescents, ensuring comprehensive vaccine effectiveness data.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
